Annals of Hepato-Biliary-Pancreatic Surgery (한국간담췌외과학회지)

The Korean Association of Hepato-Biliary-Pancreatic Surgery (한국간담췌외과학회)
권호 표지
DOI QR코드

DOI QR Code

The prognostic value of the lymph node ratio in patients with distal cholangiocarcinoma after curative intended surgery: A single-center retrospective study

  • Chaeyung Oh (Department of Surgery, Chonnam National University Medical School) ;
  • Hee Joon Kim (Department of Surgery, Chonnam National University Medical School) ;
  • Sang Hwa Song (Department of Surgery, Chonnam National University Medical School) ;
  • Eun Kyu Park (Department of Surgery, Chonnam National University Medical School) ;
  • Young Hoe Hur (Department of Surgery, Chonnam National University Medical School) ;
  • Yang Seok Koh (Department of Surgery, Chonnam National University Medical School) ;
  • Chol Kyoon Cho (Department of Surgery, Chonnam National University Medical School)
  • Received : 2021.09.09
  • Accepted : 2021.11.02
  • Published : 2022.05.31
Download PDF
⟨ Previous Next ⟩

Abstract

Backgrounds/Aims: The goal of the present study was to evaluate the prognostic value of lymph node ratio (LNR) in distal cholangiocarcinoma (DCC) after curative intended surgery. Methods: Clinicopathological data of 162 DCC patients who underwent radical intended surgery between 2012 and 2020 were analyzed retrospectively. Prognostic factors related to overall survival (OS) and disease-free survival (DFS) were evaluated. Results: Median OS time and DFS time were 41 and 29 months, and 5-year OS rate and DFS rate were 44.7% and 38.1%, respectively. In the univariate analysis, significant prognostic factors for OS were histologic differentiation, American Joint Committee on Cancer (AJCC) stage, positive lymph node count, LNR, R1 resection, and perineural invasion. Preoperative carcinoembryonic antigen, carbohydrate antigen 19-9, infiltrative type, histologic differentiation, AJCC stage, positive lymph node count, LNR, R1 resection, perineural invasion, and lymph-vascular invasion were significant prognostic factors for DFS in the univariate analysis. In the multivariate analysis, histologic differentiation, R1 resection, and LNR were the independent prognostic factors for both OS and DFS. The LNR ≥ 0.2 group had a significantly poor prognosis in terms of OS (hazard ratio, 3.915; p = 0.002) and DFS (hazard ratio, 5.840; p < 0.001). Conclusions: LNR has significant value as a prognostic factor of DCC related to OS and DFS. LNR has the potential to be used as a modified staging system with furthermore studies.

Keywords

References

  1. Gonzalez RS, Bagci P, Basturk O, Reid MD, Balci S, Knight JH, et al. Intrapancreatic distal common bile duct carcinoma: analysis, staging considerations, and comparison with pancreatic ductal and ampullary adenocarcinomas. Mod Pathol 2016;29:1358-1369. https://doi.org/10.1038/modpathol.2016.125
  2. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463-473; discussion 473-475. https://doi.org/10.1097/00000658-199610000-00005
  3. Launois B, Reding R, Lebeau G, Buard JL. Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg 2000;7:128-134. https://doi.org/10.1007/s005340050166
  4. Murakami Y, Uemura K, Sudo T, Hashimoto Y, Nakashima A, Kondo N, et al. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 2011;18:651-658. https://doi.org/10.1245/s10434-010-1325-4
  5. Kim BH, Kim K, Chie EK, Kwon J, Jang JY, Kim SW, et al. Long-term outcome of distal cholangiocarcinoma after pancreaticoduodenectomy followed by adjuvant chemoradiotherapy: a 15-year experience in a single institution. Cancer Res Treat 2017;49:473-483. https://doi.org/10.4143/crt.2016.166
  6. Strijker M, Belkouz A, Van Der Geest LG, Van Gulik TM, Van Hooft JE, De Meijer VE, et al. Treatment and survival of resected and unresected distal cholangiocarcinoma: a nationwide study. Acta Oncol 2019;58:1048-1055. https://doi.org/10.1080/0284186X.2019.1590634
  7. Hayashi H, Jang JY, Kim KS, Choi JS, Takahara T, Choi SH, et al. Comparison of pancreaticoduodenectomy and bile duct resection for middle bile duct cancer: a multi-center collaborating study of Japan and Korea. J Hepatobiliary Pancreat Sci 2020;27:289-298. https://doi.org/10.1002/jhbp.724
  8. Lee HG, Lee SH, Yoo DD, Paik KY, Heo JS, Choi SH, et al. Carcinoma of the middle bile duct: is bile duct segmental resection appropriate? World J Gastroenterol 2009;15:5966-5971. https://doi.org/10.3748/wjg.15.5966
  9. Schreuder AM, Engelsman AF, Van Roessel S, Verheij J, Besselink MG, Van Gulik TM, et al. Treatment of mid-bile duct carcinoma: local resection or pancreatoduodenectomy? Eur J Surg Oncol 2019;45:2180-2187. https://doi.org/10.1016/j.ejso.2019.06.032
  10. Akita M, Ajiki T, Ueno K, Tsugawa D, Tanaka M, Kido M, et al. Benefits and limitations of middle bile duct segmental resection for extrahepatic cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2020;19:147-152. https://doi.org/10.1016/j.hbpd.2020.01.002
  11. Komaya K, Ebata T, Shirai K, Ohira S, Morofuji N, Akutagawa A, et al. Recurrence after resection with curative intent for distal cholangiocarcinoma. Br J Surg 2017;104:426-433. https://doi.org/10.1002/bjs.10452
  12. Ercolani G, Dazzi A, Giovinazzo F, Ruzzenente A, Bassi C, Guglielmi A, et al. Intrahepatic, peri-hilar and distal cholangiocarcinoma: three different locations of the same tumor or three different tumors? Eur J Surg Oncol 2015;41:1162-1169. https://doi.org/10.1016/j.ejso.2015.05.013
  13. Sakata J, Wakai T, Matsuda Y, Ohashi T, Hirose Y, Ichikawa H, et al. Comparison of number versus ratio of positive lymph nodes in the assessment of lymph node status in extrahepatic cholangiocarcinoma. Ann Surg Oncol 2016;23:225-234. https://doi.org/10.1245/s10434-015-4609-x
  14. Kim HJ, Kim CY, Hur YH, Koh YS, Kim JC, Kim HJ, et al. Prognostic factors for survival after curative resection of distal cholangiocarcinoma: perineural invasion and lymphovascular invasion. Surg Today 2014;44:1879-1886. https://doi.org/10.1007/s00595-014-0846-z
  15. Kawai M, Tani M, Kobayashi Y, Tsuji T, Tabuse K, Horiuchi T, et al. The ratio between metastatic and examined lymph nodes is an independent prognostic factor for patients with resectable middle and distal bile duct carcinoma. Am J Surg 2010;199:447-452. https://doi.org/10.1016/j.amjsurg.2009.01.019
  16. Kiriyama M, Ebata T, Aoba T, Kaneoka Y, Arai T, Shimizu Y, et al. Prognostic impact of lymph node metastasis in distal cholangiocarcinoma. Br J Surg 2015;102:399-406. https://doi.org/10.1002/bjs.9752
  17. Murakami Y, Uemura K, Hayashidani Y, Sudo T, Ohge H, Sueda T. Pancreatoduodenectomy for distal cholangiocarcinoma: prognostic impact of lymph node metastasis. World J Surg 2007;31:337-342; discussion 343-344. https://doi.org/10.1007/s00268-006-0224-0
  18. Andrianello S, Paiella S, Allegrini V, Ramera M, Pulvirenti A, Malleo G, et al. Pancreaticoduodenectomy for distal cholangiocarcinoma: surgical results, prognostic factors, and long-term follow-up. Langenbecks Arch Surg 2015;400:623-628. https://doi.org/10.1007/s00423-015-1320-0
  19. Lyu S, Li L, Zhao X, Ren Z, Cao D, He Q. Prognostic impact of lymph node parameters in distal cholangiocarcinoma after pancreaticoduodenectomy. World J Surg Oncol 2020;18:262.
  20. Byrling J, Andersson R, Sasor A, Lindell G, Ansari D, Nilsson J, et al. Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma. Ann Gastroenterol 2017;30:571-577. https://doi.org/10.20524/aog.2017.0169
  21. Li X, Lin H, Sun Y, Gong J, Feng H, Tu J. Prognostic significance of the lymph node ratio in surgical patients with distal cholangiocarcinoma. J Surg Res 2019;236:2-11. https://doi.org/10.1016/j.jss.2018.10.044
  22. Oshiro Y, Sasaki R, Kobayashi A, Murata S, Fukunaga K, Kondo T, et al. Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholangiocarcinoma. Eur J Surg Oncol 2011;37:60-64. https://doi.org/10.1016/j.ejso.2010.10.011
  23. You Y, Shin YC, Choi DW, Heo JS, Shin SH, Kim N, et al. Proposed modification of staging for distal cholangiocarcinoma based on the lymph node ratio using Korean Multicenter Database. Cancers (Basel) 2020;12:762.
  24. Ito K, Ito H, Allen PJ, Gonen M, Klimstra D, D'Angelica MI, et al. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma. Ann Surg 2010;251:675-681.  https://doi.org/10.1097/SLA.0b013e3181d3d2b2